Stephen Gottschalk
Institution Name:
St. Jude Children's Research Hospital
Total Awards:
1
Award Value:
$11,924,780
Awards as PI
Program Type | Institution | Grant Title | Award Value |
---|---|---|---|
Clinical Trial Stage Projects | St. Jude Children's Research Hospital | Lentiviral Gene Therapy for Infants with X-linked Severe Combined Immunodeficiency using Autologous Bone Marrow Stem Cells and Busulfan Conditioning | $11,924,780 |
Total: $11,924,780.00 |
Publications
- N Engl J Med 2019 Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1. (PubMed: 30995372)
- J Allergy Clin Immunol Pract 2021 Successful SCID gene therapy in infant with disseminated BCG. (PubMed: 32949809)